TickerFactsScreenerDevelopers

Syndax Pharmaceuticals Inc (SNDX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2013: -$128.47M2014: -$152.57M2015: -$252.41M2016: $84.14M2017: $104.32M2018: $53.05M2019: $31.60M2020: $252.19M2021: $408.37M2022: $467.45M2023: $554.20M2024: $288.12M2025: $64.63M$64.63M
2013Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$64.63M-77.6%
2024$288.12M-48.0%
2023$554.20M+18.6%
2022$467.45M+14.5%
2021$408.37M+61.9%
2020$252.19M+698.1%
2019$31.60M-40.4%
2018$53.05M-49.1%
2017$104.32M+24.0%
2016$84.14M+133.3%
2015-$252.41M-65.4%
2014-$152.57M-18.8%
2013-$128.47M—